The problem with treating Alzheimer’s is that once the symptoms start showing up, it’s already too late—meaning that early detection is absolutely vital in coming up with working solutions. Using the power of machine learning, IBM researchers have figured out a way to detect a biological marker associated with the disease through a simple blood test. Apparently, that biological marker, which is found in spinal fluid, starts changing decades before the first signs of the disease show up. The problem is harvesting spinal fluid for testing is highly invasive and expensive, making it not ideal for an early detection procedure. What the IBM scientists have figured out is that it’s possible to identify the proteins in the blood that can predict the concentration of the biomarker in spinal fluid, making early detection not only possible but also affordable. The method is still in its early stages of testing, but in the future, scientists could use it to find appropriate subjects for programs developing a cure.
IBM is using machine learning to detect Alzheimer’s way before symptoms show up
More of Today's Solutions
Yangtze River sees major ecological recovery after China’s fishing ban
BY THE OPTIMIST DAILY EDITORIAL TEAM After decades of ecological decline, China’s Yangtze River, Asia’s longest and one of the most degraded waterways in ...
Read More10 brain-boosting hobbies for older adults that help keep the brain and body ...
BY THE OPTIMIST DAILY EDITORIAL TEAM Many people yearn for the golden years of retirement, where the grind often slows down, and we have ...
Read MoreNavigating counteroffers: a complete guide to making the right career move
Starting a job search is like stepping onto a carousel of potential opportunities. Once you secure that amazing new job offer, the excitement is palpable. But what if, just ...
Read MoreAre holiday tunes good for your health? Here’s what science says
BY THE OPTIMIST DAILY EDITORIAL TEAM Love it or hate it, Christmas music is an inescapable part of the holiday season. For some, it’s ...
Read More
